Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 2
This study is looking at having axitinib before surgery for kidney cancer to help shrink the cancer or stop it growing. It is open to people who can have surgery to remove all, or part, of their cancer.
Recruitment start: 1 December 2017
Recruitment end: 30 November 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Grant Stewart
Common Services Agency (CSA)
NHS National Services Scotland
Pfizer
Scottish Clinical Trials Research Unit (SCTRU)
Last reviewed: 10 Dec 2019
CRUK internal database number: 14833